Lantheus

Lantheus company information, Employees & Contact Information

Explore related pages

Related company profiles:

With more than 65 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease. Lantheus is headquartered in Massachusetts and has offices in Canada and Sweden.

Company Details

Employees
1.22K
Founded
-
Address
201 Burlington Road, South Building,united States
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Bedford, Massachusetts
Looking for a particular Lantheus employee's phone or email?

Lantheus Questions

News

Lantheus Holdings, Inc. Announces FDA Acceptance of NDA for MK-6240, a New Alzheimer’s Disease Diagnostic Imaging Agent - Quiver Quantitative

Lantheus Holdings, Inc. Announces FDA Acceptance of NDA for MK-6240, a New Alzheimer’s Disease Diagnostic Imaging Agent Quiver Quantitative

Lantheus (NASDAQ: LNTH) NDA for MK-6240 Tau PET accepted; FDA sets PDUFA Aug 13, 2026 - Stock Titan

Lantheus (NASDAQ: LNTH) NDA for MK-6240 Tau PET accepted; FDA sets PDUFA Aug 13, 2026 Stock Titan

Lantheus Holdings, Inc. to Host Conference Call for Q3 2025 Financial Results and Business Update - Quiver Quantitative

Lantheus Holdings, Inc. to Host Conference Call for Q3 2025 Financial Results and Business Update Quiver Quantitative

Lantheus to Host Third Quarter 2025 Earnings Conference Call and Webcast on November 6, 2025, at 8:00 a.m. Eastern Time - The Manila Times

Lantheus to Host Third Quarter 2025 Earnings Conference Call and Webcast on November 6, 2025, at 8:00 a.m. Eastern Time The Manila Times

Lantheus (NASDAQ: LNTH) to host third quarter earnings call on November 6 at 8:00 a.m. ET - Stock Titan

Lantheus (NASDAQ: LNTH) to host third quarter earnings call on November 6 at 8:00 a.m. ET Stock Titan

Lantheus: 30th Annual Charity Golf Tournament to Benefit Alzheimer’s Association - Foley Hoag

Lantheus: 30th Annual Charity Golf Tournament to Benefit Alzheimer’s Association Foley Hoag

Lantheus Holdings Completes Acquisition of Life Molecular Imaging, Appoints Dr. Ludger Dinkelborg as Head of R&D - Nasdaq

Lantheus Holdings Completes Acquisition of Life Molecular Imaging, Appoints Dr. Ludger Dinkelborg as Head of R&D Nasdaq

Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader - PR Newswire

Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader PR Newswire

Lantheus Holdings and GE HealthCare Announce Exclusive Licensing Agreement for PYLARIFY® in Japan for Prostate Cancer Diagnostics | LNTH Stock News - Quiver Quantitative

Lantheus Holdings and GE HealthCare Announce Exclusive Licensing Agreement for PYLARIFY® in Japan for Prostate Cancer Diagnostics | LNTH Stock News Quiver Quantitative

Lantheus Sets Q2 2025 Earnings Call Date: How to Join and What to Expect on August 6 - Stock Titan

Lantheus Sets Q2 2025 Earnings Call Date: How to Join and What to Expect on August 6 Stock Titan

Lantheus Holdings, Inc. Announces FDA Acceptance of New Drug Application for Enhanced PSMA PET Imaging Agent to Improve Patient Access - Quiver Quantitative

Lantheus Holdings, Inc. Announces FDA Acceptance of New Drug Application for Enhanced PSMA PET Imaging Agent to Improve Patient Access Quiver Quantitative

Leading Radiopharmaceutical Company Lantheus to Present at Morgan Stanley Healthcare Conference 2025 - Stock Titan

Leading Radiopharmaceutical Company Lantheus to Present at Morgan Stanley Healthcare Conference 2025 Stock Titan

500,000 US Scans: Lantheus' PYLARIFY Prostate Cancer Agent Expands to World's 3rd Largest Market via GE Deal - Stock Titan

500,000 US Scans: Lantheus' PYLARIFY Prostate Cancer Agent Expands to World's 3rd Largest Market via GE Deal Stock Titan

Lantheus Holdings, Inc. Announces Positive Results for MK-6240, a Potential Alzheimer's Disease Diagnostic Tool - Quiver Quantitative

Lantheus Holdings, Inc. Announces Positive Results for MK-6240, a Potential Alzheimer's Disease Diagnostic Tool Quiver Quantitative

Strategic Shift: Lantheus Divests Legacy SPECT Business to Accelerate Growth in Innovative Radiopharmaceuticals - Stock Titan

Strategic Shift: Lantheus Divests Legacy SPECT Business to Accelerate Growth in Innovative Radiopharmaceuticals Stock Titan

Lantheus's Revolutionary Alzheimer's Brain Scan Hits Major Milestone, FDA Filing Next - Stock Titan

Lantheus's Revolutionary Alzheimer's Brain Scan Hits Major Milestone, FDA Filing Next Stock Titan

Lantheus Holdings, Inc. Announces Acquisition of Life Molecular Imaging Ltd. to Enhance Alzheimer’s Disease Diagnostic Capabilities with Neuraceq® Integration - Nasdaq

Lantheus Holdings, Inc. Announces Acquisition of Life Molecular Imaging Ltd. to Enhance Alzheimer’s Disease Diagnostic Capabilities with Neuraceq® Integration Nasdaq

Lantheus to Acquire Evergreen Theragnostics for $250 Million - citybiz

Lantheus to Acquire Evergreen Theragnostics for $250 Million citybiz

Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million - citybiz

Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million citybiz

How Lantheus' PYLARIFY Hit Blockbuster Status While Profits Declined: Q4 Earnings Breakdown - Stock Titan

How Lantheus' PYLARIFY Hit Blockbuster Status While Profits Declined: Q4 Earnings Breakdown Stock Titan

Lantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8:00 a.m. Eastern Time - The Manila Times

Lantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8:00 a.m. Eastern Time The Manila Times

Lantheus' PYLARIFY Set to Hit $1B Sales as CMS Updates Medicare Payment Rules - Stock Titan

Lantheus' PYLARIFY Set to Hit $1B Sales as CMS Updates Medicare Payment Rules Stock Titan

Lantheus Promotes Amanda Morgan to Chief Commercial Officer - citybiz

Lantheus Promotes Amanda Morgan to Chief Commercial Officer citybiz

Lantheus Appoints Brian Markison as CEO - citybiz

Lantheus Appoints Brian Markison as CEO citybiz

Lantheus to Sell RELISTOR Royalties to HealthCare Royalty - citybiz

Lantheus to Sell RELISTOR Royalties to HealthCare Royalty citybiz

Lantheus Appoints Jeffrey Humphrey CMO and Jean-Claude Provost CSO - citybiz

Lantheus Appoints Jeffrey Humphrey CMO and Jean-Claude Provost CSO citybiz

Lantheus Holdings Reports First Quarter 2021 Financial Results - citybiz

Lantheus Holdings Reports First Quarter 2021 Financial Results citybiz

Lantheus to Present Additional Clinical Data from Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024 - Stock Titan

Lantheus to Present Additional Clinical Data from Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024 Stock Titan

Lantheus and POINT Biopharma Announce Strategic - GlobeNewswire

Lantheus and POINT Biopharma Announce Strategic GlobeNewswire

Lantheus and POINT Biopharma Announce Positive Topline - GlobeNewswire

Lantheus and POINT Biopharma Announce Positive Topline GlobeNewswire

Lantheus and Progenics Reschedule Their Respective Special Meetings of Stockholders for Proposed Merger - Business Wire

Lantheus and Progenics Reschedule Their Respective Special Meetings of Stockholders for Proposed Merger Business Wire

LNTH - Lantheus Holding Latest Stock News & Market Updates - Stock Titan

LNTH - Lantheus Holding Latest Stock News & Market Updates Stock Titan

Lantheus and GE Healthcare Sign Agreement for Worldwide Development, Commercialization of Flurpiridaz F-18 - Imaging Technology News

Lantheus and GE Healthcare Sign Agreement for Worldwide Development, Commercialization of Flurpiridaz F-18 Imaging Technology News

Jubilant HollisterStier Approved by FDA to Manufacture Lantheus' Neurolite - Imaging Technology News

Jubilant HollisterStier Approved by FDA to Manufacture Lantheus' Neurolite Imaging Technology News

Lantheus Holdings Announces First Commercial Shipment of Xenon 133 Gas - Imaging Technology News

Lantheus Holdings Announces First Commercial Shipment of Xenon 133 Gas Imaging Technology News

Lantheus Medical Imaging Announces Xenon 133 Supply Agreement with Institute for Radioelements - Imaging Technology News

Lantheus Medical Imaging Announces Xenon 133 Supply Agreement with Institute for Radioelements Imaging Technology News

Lantheus and Fujifilm Renew Long-Term Agreement for Cardiolite and Neurolite in Japan - Imaging Technology News

Lantheus and Fujifilm Renew Long-Term Agreement for Cardiolite and Neurolite in Japan Imaging Technology News

Top Lantheus Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant